Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
J Ethnopharmacol ; 261: 113203, 2020 Oct 28.
Article de Anglais | MEDLINE | ID: mdl-32721552

RÉSUMÉ

ETHNOPHARMACOLOGICAL RELEVANCE: Diabetic foot ulcer is one of the most serious complications of diabetes. Effective medical treatment regarding improvement of ulcer healing in patients is essential. Pien Tze Huang (PZH), a valuable Chinese traditional medicine, has been found significant efficacy on the curing of diabetic wound in clinic recently. AIM OF THE STUDY: This work was conducted to confirm the efficacy, and compare the therapeutic effect through the oral administration and local delivery route, providing a rationale for the new PZH form development; besides, the mechanisms through which PZH promoted the wound healing was also discussed. MATERIALS AND METHODS: First, the chemical composition of PZH was characterized by 1H-NMR and HPLC. The anti-apoptosis effects of PZH on high concentration glucose injured epidermal fibroblast (HFF-1) was investigated in a dose dependent way. Then, the effects of the systematical administration of PZH, and the topical used route on excisional wounds of Streptozotocin (STZ) induced diabetic mice were compared. RESULTS: The results illustrated that PZH decreased the reactive oxygen species (ROS) levels in cells, preventing cell damage/apoptosis through an ROS/Bcl-2/Bax/Caspase-3 pathway. The in vivo study proved that topical use of PZH exceeded the systematical route both in accelerating the wound closure and improving the healing quality. Meanwhile, PZH promoted wound closure through stimulating the secretion of Col-I, decreasing fibroblast apoptosis, and enhancing myo-fibroblast differentiation, in consistent with the mechanism study in vitro. CONCLUSIONS: Local used PZH improves wound healing by inhibiting the abnormal HFF-1 apoptosis and senescence. The study held a great promise for development of a topical dosage form of PZH for diabetic wound healing.


Sujet(s)
Apoptose/effets des médicaments et des substances chimiques , Médicaments issus de plantes chinoises/pharmacologie , Fibroblastes/effets des médicaments et des substances chimiques , Myofibroblastes/effets des médicaments et des substances chimiques , Peau/effets des médicaments et des substances chimiques , Cicatrisation de plaie/effets des médicaments et des substances chimiques , Plaies et blessures/traitement médicamenteux , Administration par voie cutanée , Administration par voie orale , Animaux , Protéines régulatrices de l'apoptose/métabolisme , Glycémie/métabolisme , Différenciation cellulaire/effets des médicaments et des substances chimiques , Lignée cellulaire , Prolifération cellulaire/effets des médicaments et des substances chimiques , Diabète expérimental/sang , Diabète expérimental/induit chimiquement , Médicaments issus de plantes chinoises/administration et posologie , Fibroblastes/métabolisme , Fibroblastes/anatomopathologie , Mâle , Souris de lignée C57BL , Myofibroblastes/métabolisme , Myofibroblastes/anatomopathologie , Espèces réactives de l'oxygène/métabolisme , Peau/traumatismes , Peau/métabolisme , Peau/anatomopathologie , Streptozocine , Facteurs temps , Plaies et blessures/complications , Plaies et blessures/métabolisme , Plaies et blessures/anatomopathologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE